SL

Starling Locke Capital

Description

Starling Locke Capital operates has investment.

Investor Profile

Starling Locke Capital has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 100% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Life Science.

Stage Focus

  • Series B (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Starling Locke Capital frequently co-invest with?

LA
Europe, Schwyz, Switzerland, Freienbach
Co-Investments: 1

What are some of recent deals done by Starling Locke Capital?

X-Therma

Richmond, California, United States

X-Therma is a biotechnology firm that develops a convergent biopreservation platform to advance regenerative medicine.

BiotechnologyHealth CareLife Science
Series BMar 13, 2024
Amount Raised: $22,400,000